|Articles|January 1, 2020
- Pharmaceutical Executive-01-01-2020
- Volume 40
- Issue 1
Pharmaceutical Executive, January 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec’s 2020 Industry Outlookover 6 years ago
Sharing the Pricing Stage in 2020over 6 years ago
Paving Bayer’s Future Pathover 6 years ago
Politics & Pricing to Shape Pharma Prospects in 2020over 6 years ago
Pharma’s Brexit Routeover 6 years ago
Is the Tail Wagging the Dog in Drug Market Entry?over 6 years ago
A Happy New Year for European Pharma Policy?over 6 years ago
Deeper Dive: Gene Therapy Manufacturingover 6 years ago
Country Report: ChinaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing
4
Rethinking Pharma's Go-to-Market Formula
5